Impact of renal disease in cardiovascular surgery: emphasis on the African-American patient  William A Cooper, MD, William Brinkman, MD, Rebecca J Petersen,

Slides:



Advertisements
Similar presentations
Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Scope of Coronary Heart Disease in Patients With.
Advertisements

2016 Annual Data Report, Vol 2, ESRD, Ch 5
Figure 9.1 Causes of death in ESRD patients,
2016 Annual Data Report, Vol 2, ESRD, Ch 6
Robert A. Guyton, MD  The Annals of Thoracic Surgery 
Patient populations by study group figure 10
Chapter 8: Cardiovascular Disease in Patients with ESRD
Volume 68, Pages S46-S52 (August 2005)
Summary of the 2013 ERA-EDTA Registry Annual Report
Volume 2: End-Stage Renal Disease Chapter 4: Hospitalization
Ten-year trends in heart valve replacement operations
Elevated Preoperative Hemoglobin A1c Level is Associated With Reduced Long-Term Survival After Coronary Artery Bypass Surgery  Michael E. Halkos, MD,
December 31st point prevalent counts by modality figure 3.1
Chapter 9: Healthcare Expenditures for Persons with ESRD
Early postoperative outcome and medium-term survival in 540 diabetic and 2239 nondiabetic patients undergoing coronary artery bypass grafting  Zoltán.
Figure 1.17 of the 2016 US Renal Data System Annual Data Report, Volume 2, chapter 1 showing the trends in the number of patients with incident ESRD (in.
Diabetic Kidney Disease: An ACEI (or an ARB) in the Hole
Leena Khaitan, MD, Francis P Sutter, Scott M Goldman, MD 
Magnitude of Negative Impact of Preoperative Heart Failure on Mortality During Aortic Valve Replacement in the Medicare Population  Christina M. Vassileva,
Robert A. Guyton, MD  The Annals of Thoracic Surgery 
Coronary Artery Surgery
Coronary artery bypass grafting in patients with advanced left ventricular dysfunction  Gregory D Trachiotis, MD, William S Weintraub, MD, Thomas S Johnston,
Chapter 8: Cardiovascular Disease in Patients with ESRD
James Edgerton, MD, Giovanni Filardo, PhD, MPH, William H
Impact of Preoperative Renal Dysfunction on Long-Term Survival for Patients Undergoing Aortic Valve Replacement  Vinod H. Thourani, MD, W. Brent Keeling,
Michael E. Halkos, MD, Patrick Kilgo, MS, Omar M
The Impact of Specific Preoperative Organ Dysfunction in Patients Undergoing Aortic Valve Replacement  Vinod H. Thourani, MD, Ritam Chowdhury, MD, Rebecca.
David Badrudin, MD, Feras Khaliel, MD, Raymond Cartier, MD 
Fig 6.1 Frequency of ischaemic heart disease in incident patients
Trends in Acute Kidney Injury, Associated Use of Dialysis, and Mortality After Cardiac Surgery, 1999 to 2008  Colin R. Lenihan, MBBCh, BAO, Maria E. Montez-Rath,
Elevated Preoperative Hemoglobin A1c Level is Associated With Reduced Long-Term Survival After Coronary Artery Bypass Surgery  Michael E. Halkos, MD,
Michael Frenken, MD, Arno Krian, MD  The Annals of Thoracic Surgery 
The Society of Thoracic Surgeons Thoracic Surgery Practice and Access Task Force: 2014 Workforce Report  John S. Ikonomidis, MD, PhD  The Annals of Thoracic.
Frederick L Grover, MD  The Annals of Thoracic Surgery 
Ten-year trends in heart valve replacement operations
Long-Term Survival of Patients With Ischemic Cardiomyopathy Treated by Coronary Artery Bypass Grafting Versus Medical Therapy  Eric J. Velazquez, MD,
New-Onset Postoperative Atrial Fibrillation and Long-Term Survival After Aortic Valve Replacement Surgery  Giovanni Filardo, PhD, MPH, Cody Hamilton,
Donald S. Likosky, PhD, Stephen D. Surgenor, MD, Robert S
Potassium and Magnesium Supplementation Do Not Protect Against Atrial Fibrillation After Cardiac Operation: A Time-Matched Analysis  Timothy S. Lancaster,
Public policy and the practicing physician
Performing Coronary Artery Bypass Grafting Off-Pump May Compromise Long-Term Survival in a Veteran Population  Faisal G. Bakaeen, MD, Danny Chu, MD, Rosemary.
Acute myocardial infarction in patients with chronic kidney disease: how are the most vulnerable patients doing?  Gautam R. Shroff, Charles A. Herzog 
Geriatrics American Journal of Kidney Diseases
Long-Term Survival After Coronary Arterial Grafts in Patients With End-Stage Renal Disease  Taro Nakatsu, MD, Nobushige Tamura, MD, PhD, Yutaka Sakakibara,
Bartosz Rylski, MD, Nimesh D. Desai, MD, PhD, Joseph E
Volume 68, Pages S46-S52 (August 2005)
Vinod H. Thourani, MD, Vinay Badhwar, MD, David M. Shahian, MD, Fred H
Terry Shih, MD, Justin B. Dimick, MD, MPH 
Trends in Hospitalizations Among Medicare Survivors of Aortic Valve Replacement in the United States From 1999 to 2010  Karthik Murugiah, MD, Yun Wang,
Aortic Valve Replacement for Patients With Severe Aortic Stenosis: Risk Factors and Their Impact on 30-Month Mortality  Edward L. Hannan, PhD, Zaza Samadashvili,
American Journal of Kidney Diseases
Lynda Anne Szczech, Ira L. Lazar  Kidney International 
Racial disparities in kidney health: The puzzle to solve
Peter J. Conlon, Mark A. Little, Karen Pieper, Daniel B. Mark 
Limitations of Hospital Volume as a Measure of Quality of Care for Coronary Artery Bypass Graft Surgery  Karl F. Welke, MD, Mitchell J. Barnett, PharmD,
Unraveling the racial disparities associated with kidney disease1
The Use of Vaccines in Adult Patients With Renal Disease
Long-term outcome of dialysis patients in the United States with coronary revascularization procedures  Charles A. Herzog, M.D., Jennie Z. Ma, Allan J.
Trends in Patient Characteristics and Outcomes of Coronary Artery Bypass Grafting in the 2000 to 2012 Medicare Population  Christian McNeely, MD, Stephen.
Collecting and using patient and treatment center data to improve care: Adequacy of hemodialysis and end-stage renal disease surveillance1  William M.
Aprotinin is Not Associated With Postoperative Renal Impairment After Primary Coronary Surgery  Gabriella Lindvall, MD, Ulrik Sartipy, MD, PhD, Torbjörn.
Improved Long-Term Survival for Diabetic Patients With Surgical Versus Interventional Revascularization  Paul Kurlansky, MD, Morley Herbert, PhD, Syma.
Survival and Quality of Life for Nonagenarians After Cardiac Surgery
Increased Rehospitalization Rate After Coronary Bypass Operation for Acute Coronary Syndrome: A Prospective Study in 200 Patients  Staffan Bjessmo, MD,
Minimally invasive direct coronary artery bypass, percutaneous transluminal coronary angioplasty, and stent placement for left main stenosis  William.
Influence of concomitant CABG and urgent/emergent status on mitral valve replacement surgery  Vinod H Thourani, MD, William S Weintraub, MD, Joseph M.
Dumbor L. Ngaage, MD, FRCS (C-Th), Michael E. Cowen, FRCS 
The Impact of New Technology on Cardiothoracic Surgical Practice
Figure 9.1.a Causes of death in ESRD patients,
Magnus Dalén, MD, Torbjörn Ivert, MD, PhD, Martin J
Presentation transcript:

Impact of renal disease in cardiovascular surgery: emphasis on the African-American patient  William A Cooper, MD, William Brinkman, MD, Rebecca J Petersen, RN, BA, Robert A Guyton, MD  The Annals of Thoracic Surgery  Volume 76, Issue 4, Pages S1370-S1376 (October 2003) DOI: 10.1016/S0003-4975(03)01204-9

Fig 1 Trends in incident rates and annual percent change. Rates adjusted for age, gender, and race. The incidence of dialysis dependent renal failure has continued to increase over the past 20 years. The rate of new cases increased by 5% to 10% over this time period. The overall incidence is higher in the African American subgroup, however, new cases are similar to Caucasians. [Reprinted from U.S. Renal Data System, USRDS 2002 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2002. The interpretation and reporting of these data are the responsibility of the author(s) and in no way should be seen as an official policy or interpretation of the U.S. government.] The Annals of Thoracic Surgery 2003 76, S1370-S1376DOI: (10.1016/S0003-4975(03)01204-9)

Fig 2 Annual trend of dialysis-dependent open heart procedures from Crawford Long and Emory University Hospitals from 1994 through 2001. The Annals of Thoracic Surgery 2003 76, S1370-S1376DOI: (10.1016/S0003-4975(03)01204-9)

Fig 3 Costs of the end-stage renal disease (ESRD) and Medicare program dollars in 2000 are inflated by 2% to account for costs incurred not reported. Medicare expenditures have increased coincident with the increasing number of patients requiring dialysis. Annual cost has more than doubled and the percent of expenditures allocated to dialysis programs have increased similarly (green line = total medicare dollars; red line = total dialysis dollars; blue bars = ESRD percent of medicare dollars). [Reprinted from U.S. Renal Data System, USRDS 2002 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2002. The interpretation and reporting of these data are the responsibility of the author(s) and in no way should be seen as an official policy or interpretation of the U.S. government.] The Annals of Thoracic Surgery 2003 76, S1370-S1376DOI: (10.1016/S0003-4975(03)01204-9)

Fig 4 All cause survival; results of invasive coronary artery procedures in dialysis patients could be of some inherent benefit. It remains to be demonstrated in a prospective fashion which procedures may have the most impact on patient long-term survival. (CAB = coronary artery bypass; IMA = internal mammary artery; PTCA = percutaneous transluminal coronary angioplasty.) The Annals of Thoracic Surgery 2003 76, S1370-S1376DOI: (10.1016/S0003-4975(03)01204-9)

Fig 5 Incident end-stage renal disease (ESRD) and survival probability adjusted for age, gender, race, and primary diagnosis. The incident cohorts and associated modalities are determined at the time of ESRD initiation with the 60-day stable modality rule and the 90-day rule. Age as of date of ESRD initiation. Unknown age, gender; other and unknown, and primary diagnosis are excluded. [Reprinted from U.S. Renal Data System, USRDS 2002 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2002. The interpretation and reporting of these data are the responsibility of the author(s) and in no way should be seen as an official policy or interpretation of the U.S. government.] The Annals of Thoracic Surgery 2003 76, S1370-S1376DOI: (10.1016/S0003-4975(03)01204-9)

Fig 6 Mortality by creatinine clearance from The Society of Thoracic Surgeons national adult cardiac registry of coronary artery bypass procedures, May 2000 through December 2001. Although African-American patients tend to live longer once dialysis is initiated, the impact of renal dysfunction on those undergoing coronary artery bypass procedures is profound. No appreciable ethnic differences exist in coronary artery bypass patients. The Annals of Thoracic Surgery 2003 76, S1370-S1376DOI: (10.1016/S0003-4975(03)01204-9)

Fig 7 Annual trend of dialysis dependent coronary artery bypass (CAB) or valve procedures at Crawford Long and Emory University Hospitals from 1994 through 2001. (ESRD = end-stage renal disease.) The Annals of Thoracic Surgery 2003 76, S1370-S1376DOI: (10.1016/S0003-4975(03)01204-9)